Presentation TCT 2016 Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes? Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith October 30, 2016
Presentation TCT 2016 Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy October 30, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma October 30, 2016
News Daily News FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy L.A. McKeown October 27, 2016
News Daily News Registro FRANCE 2: 3 Años Después de una TAVR, el Rendimiento de la Válvula se Mantiene y casi Toda la Mortalidad es No Cardíaca Caitlin E. Cox October 04, 2016
News Daily News At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry Caitlin E. Cox October 04, 2016
News Daily News La Cognición Post-TAVR Mejora en Algunos Pacientes y Desciende en Otros y son Pocas las Señales Orientativas Shelley Wood September 29, 2016
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Daily News Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients L.A. McKeown August 24, 2016
News Daily News Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo L.A. McKeown August 24, 2016
News Daily News Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter Michael O'Riordan August 18, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016
News Daily News Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas Todd Neale July 14, 2016